-
Spinal Cord Injury Awareness Month - September 2017
-
Pain Awareness Month - September 2017
-
Hospira Issues Voluntary Worldwide Recall For Lots of Hydromorphone HCl Injection, USP, CII, (2 mg/mL) 1mg/mL Vial, and Levophed® (Norepinephrine Bitartrate Injection, USP), 4 mg/4 mL (1 mg/mL) Vial, Due to a Lack of Sterility Assurance
-
Let’s Celebrate Women in Medicine Month
-
AAPM&R Members in the News: August 2017
-
August Coding Q&A
-
Annual Assembly Early-Bird Savings End August 30!
-
AAPM&R Submits Comments on the 2018 Proposed Updates to the Quality Payment Program
-
Bella Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of All Sterile Drug Products Due to Lack of Sterility Assurance
-
Postponed: August 22 Town Hall: Health Care Reform on the Hill
-
CMS Proposes Changes to the Comprehensive Care for Joint Replacement Model, cancellation of the mandatory Episode Payment Models and Cardiac Rehabilitation Incentive Payment Model
-
Lorazepam Oral Concentrate, USP 2mg/mL by Amneal Pharmaceuticals: Recall - Misprinted Dosing Droppers
-
Registry Participant Spotlight: East Idaho Sports, Spine and Rehab Center
-
Pravastatin Sodium Tablets by International Laboratories: Recall - Mislabeling
-
International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A
-
Liquid-filled Intragastric Balloon Systems: Letter to Healthcare Providers - Potential Risks
-
Liquid Drug Products Manufactured by PharmaTech and Distributed by Rugby Laboratories and Possibly Other Companies: FDA Advisory - Not to Use
-
#PhysiatryDay2017: Call for Content
-
Look for Your August Issue of The Physiatrist
-
New Audio Resource: 2016 Annual Assembly Cancer Summit: Integration into Practice